Hyperactivity News and Research

RSS

AssureRx introduces new pharmacogenomic test for ADHD

AssureRx Health, Inc. today announced it has launched a personalized medicine test for the growing number of children and adults diagnosed with attention deficit hyperactivity disorder (ADHD). The new pharmacogenomic test can assist clinicians with important medication decisions that result from genomic differences in how individual patients tolerate ADHD medications.

7 May 2012

Autism researcher awarded $1 million grant to apply virtual-reality technology

UC Davis autism researcher and education specialist Peter Mundy has received a $1 million grant from the U.S. Department of Education to apply virtual-reality technology to evaluate social attention and its relation to academic achievement among school children with autism.

3 May 2012

Excessive daytime sleepiness may cause learning, attention and behavior problems

Children who have learning, attention and behavior problems may be suffering from excessive daytime sleepiness, even though clinical tests show them sleeping long enough at night, a new study reports.

2 May 2012

Vessix V2 Renal Denervation System for hypertension receives CE Mark approval

Vessix Vascular, Inc., a developer of novel percutaneous radiofrequency (RF) balloon catheter technology for the treatment of hypertension, announced today that it has received Conformite Europeenne (CE) Mark approval for its V2 Renal Denervation System for the treatment of hypertension.

2 May 2012

High-dose glucocorticoids double risk of bacterial infections in children with JIA

Children with juvenile idiopathic arthritis have higher rates of bacterial infection requiring hospitalization, and use of high-dose steroids significantly increases that risk, according to research from the University of Alabama at Birmingham.

2 May 2012

High-dose steroids increase infection risk in children with juvenile idiopathic arthritis

Children with juvenile idiopathic arthritis (JIA) have higher rates of hospitalized bacterial infection than children without JIA according to an observational study appearing in Arthritis & Rheumatism, a journal published by Wiley-Blackwell on behalf of the American College of Rheumatology (ACR).

2 May 2012

Teenage risky behaviors can be traced to special brain wiring: Study

New research suggests that there is a complex networks of neurons in some youngsters’ brains that make them more likely to begin smoking, experimenting with cannabis or consuming large amounts of alcohol.

30 Apr 2012

Scientists discover number of unknown brain networks linked with teen drug abuse

Why do some teenagers start smoking or experimenting with drugs-while others don't? In the largest imaging study of the human brain ever conducted-involving 1,896 14-year-olds-scientists have discovered a number of previously unknown networks that go a long way toward an answer.

30 Apr 2012

Bullying, ostracism strong predictors of increased symptoms of depression or anxiety

The challenges that come with battling a chronic medical condition or developmental disability are enough to get a young person down. But being left out, ignored or bullied by their peers is the main reason youths with special health care needs report symptoms of anxiety or depression, according to a study to be presented Sunday, April 29, at the Pediatric Academic Societies (PAS) annual meeting in Boston.

30 Apr 2012

Positive top-line results from Shire’s Vyvanse Phase 2 study on binge eating disorder

Shire plc, the global specialty biopharmaceutical company, today announced positive top-line results from a Phase 2 study to evaluate the safety and efficacy of Vyvanse (lisdexamfetamine dimesylate) Capsules, (CII) in adults with binge eating disorder.

27 Apr 2012

CEHC develops list of ten chemicals that contribute to autism, learning disabilities

An editorial published today in the prestigious journal Environmental Health Perspectives calls for increased research to identify possible environmental causes of autism and other neurodevelopmental disorders in America's children and presents a list of ten target chemicals including which are considered highly likely to contribute to these conditions.

26 Apr 2012

Gestational diabetes on the rise

Although the disease usually goes away after delivery, it can have permanent consequences. Not only can the mother be prone to develop diabetes later in life, but their babies are also at greater risk for chronic health problems.

16 Apr 2012

New compound reverses major symptoms associated with FXS

A recent study finds that a new compound reverses many of the major symptoms associated with Fragile X syndrome (FXS), the most common form of inherited intellectual disability and a leading cause of autism. The paper, published by Cell Press in the April 12 issue of the journal Neuron, describes the exciting observation that the FXS correction can occur in adult mice, after the symptoms of the condition have already been established.

12 Apr 2012

Methylphenidate may help induce recovery from propofol anesthesia

The ability of the commonly used stimulant methylphenidate (Ritalin) to speed recovery from general anesthesia appears to apply both to the inhaled gas isoflurane, as previously reported, and to the intravenous drug propofol. Members of the same Massachusetts General Hospital (MGH) research team that reported the isoflurane study are publishing similar results for propofol in the May issue of Anesthesiology, and their paper has been issued online.

6 Apr 2012

Early-life bisphenol A exposure affects later-stage learning impairment

In testing the effects of the controversial chemical bisphenol A (BPA) on zebrafish, UWM scientist Daniel Weber found himself in familiar territory.

5 Apr 2012

Combination of ADHD drug and parental intervention can help children with autism

Researchers at The Ohio State University are conducting a study to determine which is more effective for helping children on the autism spectrum: training parents or taking medication.

4 Apr 2012

New research: ADHD is more than one disorder

According to new research conducted at Oregon Health & Science University, Attention Deficit Hyperactivity Disorder (ADHD) is more than one disorder. It's an entire family of disorders, much like the multiple subtypes of cancer.

3 Apr 2012

Diagnostic inflation of ADHD

What experts and the public have already long suspected is now supported by representative data collected by researchers at Ruhr-Universit-t Bochum (RUB) and University of Basel: ADHD, attention deficit hyperactivity disorder, is over-diagnosed.

31 Mar 2012

“Meth” babies more at risk of behavioral problems: Study

A new study shows methamphetamine's potential lasting behavioral effects on kids of mothers who used meth during pregnancy. The behavior differences — anxiety, depression, moodiness — weren't huge, but lead researcher Linda LaGasse called them “very worrisome.”

20 Mar 2012

Pediatricians' unconscious racial bias may affect pain medication decisions

Pediatricians who show an unconscious preference for European Americans tend to prescribe better pain-management for white patients than they do for African-American patients, new University of Washington research shows.

20 Mar 2012

Hyperactivity News and Research

AssureRx introduces new pharmacogenomic test for ADHD

Autism researcher awarded $1 million grant to apply virtual-reality technology

Excessive daytime sleepiness may cause learning, attention and behavior problems

Vessix V2 Renal Denervation System for hypertension receives CE Mark approval

High-dose glucocorticoids double risk of bacterial infections in children with JIA

High-dose steroids increase infection risk in children with juvenile idiopathic arthritis

Teenage risky behaviors can be traced to special brain wiring: Study

Scientists discover number of unknown brain networks linked with teen drug abuse

Bullying, ostracism strong predictors of increased symptoms of depression or anxiety

Positive top-line results from Shire’s Vyvanse Phase 2 study on binge eating disorder

CEHC develops list of ten chemicals that contribute to autism, learning disabilities

Gestational diabetes on the rise

New compound reverses major symptoms associated with FXS

Methylphenidate may help induce recovery from propofol anesthesia

Early-life bisphenol A exposure affects later-stage learning impairment

Combination of ADHD drug and parental intervention can help children with autism

New research: ADHD is more than one disorder

Diagnostic inflation of ADHD

“Meth” babies more at risk of behavioral problems: Study

Pediatricians' unconscious racial bias may affect pain medication decisions

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News